Retour
Fourchette du Jour
48,06 €
50,60 €
Fourchette 52 Semaines
20,44 €
118,84 €
Volume
715 563
Moyenne 50J / 200J
79,67 €
/
65,69 €
Clôture Précédente
46,84 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,9 | 0,4 |
| P/B | 0,8 | 2,9 |
| ROE % | -16,1 | 3,7 |
| Net Margin % | -277,5 | 3,8 |
| Rev Growth 5Y % | 78,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 78,15% annually over 5 years — strong growth
Debt/Equity of 0,04 — conservative balance sheet
Negative free cash flow of -299,01M
PEG of 0,09 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 60,97%
Capital efficient — spends only 0,62% of revenue on capex
Croissance
Revenue Growth (5Y)
78,15%
Revenue (1Y)17,18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-16,07%
ROIC-14,97%
Net Margin-277,47%
Op. Margin-362,95%
Sécurité
Debt / Equity
0,04
Current Ratio11,97
Interest Coverage0,00
Valorisation
P/E Ratio
-4,94
P/B Ratio0,78
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,18% | Revenue Growth (3Y) | 25,73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 78,15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 147,17M | Net Income (TTM) | -408,35M |
| ROE | -16,07% | ROA | -13,97% |
| Gross Margin | -42,52% | Operating Margin | -362,95% |
| Net Margin | -277,47% | Free Cash Flow (TTM) | -299,01M |
| ROIC | -14,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 11,97 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,94 | P/B Ratio | 0,78 |
| P/S Ratio | 13,69 | PEG Ratio | 0,09 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,02B | Enterprise Value | 1,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 147,17M | 125,60M | 93,11M | 55,55M | 14,61M |
| Net Income | -408,35M | -2,03B | -1,47B | -5,40B | -1,25B |
| EPS (Diluted) | -11,11 | -63,54 | -47,20 | -173,87 | -40,18 |
| Gross Profit | -62,57M | -78,02M | -95,61M | -116,45M | -100,00M |
| Operating Income | -534,16M | -2,19B | -1,52B | -5,44B | -1,27B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,92B | 2,98B | 4,56B | 5,60B | 9,74B |
| Total Liabilities | 344,15M | 479,90M | 910,74M | 955,94M | 307,40M |
| Shareholders' Equity | 2,58B | 2,50B | 3,65B | 4,65B | 9,43B |
| Total Debt | 98,01M | 68,14M | 84,41M | 96,01M | 110,56M |
| Cash & Equivalents | 249,73M | 214,23M | 97,29M | 241,60M | 221,16M |
| Current Assets | 953,85M | 819,86M | 156,07M | 295,63M | 242,73M |
| Current Liabilities | 79,67M | 76,93M | 163,61M | 134,94M | 97,89M |